Aim To evaluate the impact of the coronavirus disease 2019 pandemic (COVID‐19) on the
access to rheumatology care for patients with chronic rheumatic diseases (CRD) in the Arab …

Abstract Objective Psoriatic arthritis (PsA), a chronic inflammatory disease characterized by
heterogeneous clinical manifestations, substantially impacts the quality of life of affected …

Systematic reviews and meta-analysis evaluating the prevalence, incidence, and
psychological comorbidities of psoriatic arthritis (PsA) are increasing, so it's time to perform …

The population-based prevalence of psoriatic arthritis (PsA) is still unclear and not well
described globally. The aim of this study was to conduct a population-based prevalence …

This review discusses the possible involvement of infections-associated cancers in humans,
with virus infections contributing 15% to 20% of total cancer cases in humans. DNA virus …

Cancer is a devastating disease which affects people and their families as well as health
care systems by 10.9 million new cases and 6.7 million deaths annually. 1 The cell-free …

Background Psoriasis is a chronic erythematous inflammatory skin disorder. The major
challenge with psoriasis is delayed diagnosis, resulting in delayed treatment initiation and …

Psoriatic arthritis (PsA) is a highly heterogeneous disease with complex manifestations.
Limited understanding of the disease and non-availability of local guidelines pose …

Background Though biologic agents have significantly improved the treatment of
inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis) …

Spondylarthritis (SpA) is an umbrella term that encompasses a wide range of
rheumatological disorders. Several studies demonstrated that SpA is associated with …